Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep562 | Pituitary and Neuroendocrinology | ECE2021

Cognitive impairment, obesity, and hypopituitarism - several entities or one syndrome?

Juliana Marques-Sá , Joana Santos Maria

IntroductionPrader-Willi syndrome (PWS) is a multisystemic genetic disorder caused by lack of expression of genes on the paternally inherited chromosome 15q11.2-q13 region. Despite PWS present manifestations from birth, affected individuals can remain undiagnosed until adulthood.Clinical caseWoman, 40 years old, with cognitive impairment, referred to endocrinology due to morbid obesity (BMI 44.5 Kg/m2</s...

ea0070aep282 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Residual fasting C-peptide secretion and its association with glycemic control in type 1 diabetes

Lopes Sara , Barbosa Mariana , Barros Inês , Sá Juliana , Joana Santos Maria , Margarida Monteiro Ana , Fernandes Vera , Matos Catarina , Lopes Pereira Maria , Marques Olinda , Alves Marta

Background: Residual C-peptide (CP) secretion has been associated with better glycemic control in patients with type 1 diabetes (T1D).Aim: To evaluate how residual fasting CP (fCP) secretion impacts glycemic control in T1D and to identify possible confounding factors.Methods: A retrospective analysis of adult patients with T1D followed in our department that had their fCP and glucose levels obtained on the same blood sample during ...

ea0070aep484 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Flash glucose monitoring system: Impact on glycaemic control and body mass index in type 1 diabetes mellitus

Sá Juliana , Lopes Sara , Barbosa Mariana , Ferreira Barros Inês , Margarida Monteiro Ana , Fernandes Vera , Matos Catarina , Alves Marta , Lopes Pereira Maria , Marques Olinda , Joana Santos Maria

Background: The use of Flash Glucose Monitoring (FGM) for the management of type 1 diabetes mellitus (T1D) is rapidly increasing.Aims: To assess the longitudinal evolution of glycated haemoglobin (HbA1c) and body mass index (BMI) with the use of FGM in patients with T1D; to determine predictive factors of benefit with the use of this technology.Materials and methods: Retrospective study of T1D patients, using FGM ≥6 months an...